Data as of 05:57 AM on Oct 21st, 2026
value
Data as of 06:05 AM on Oct 21st, 2026
| Vaccine | Immunizations |
|---|---|
| Td vaccine | 169.22K |
| DTaP-HepB-IPV-Hib vaccine | 112.31K |
| 15-valent pneumococcal conjugate vaccine | 106.55K |
| Measles, Mumps, and Rubella (MMR) combined vaccine | 97.15K |
| Tuberculosis vaccine | 56.42K |
| Rotavirus vaccine | 54.23K |
| DTaP-IPV vaccine | 49.11K |
| Purified Protein Derivative (PPD) | 47.69K |
| TDaP vaccine | 47.38K |
| Human papillomavirus (HPV) vaccine | 38.30K |
| Hepatitis B vaccine | 38.01K |
| DTaP-IPV-Hib vaccine | 36.63K |
| Varicella (chickenpox) vaccine | 25.95K |
| Tetanus vaccine | 17.25K |
| Nasal seasonal influenza vaccine | 11.99K |
| Rabies vaccine | 7.11K |
| 10-valent pneumococcal conjugate vaccine | 5.06K |
| 20-valent pneumococcal conjugate vaccine | 4.83K |
| Seasonal influenza vaccine | 3.65K |
| COVID-19 vaccine | 2.15K |
| 13-valent pneumococcal conjugate vaccine | 1.98K |
| Combined Hepatitis A and B vaccine | 1.74K |
| Meningococcal vaccine (В) | 1.62K |
| Yellow fever vaccine | 1.35K |
| Meningococcal vaccine (A, C, W135, Y) | 1.07K |
| RSV vaccine (Respiratory Syncytial Virus vaccine) | 783 |
| Hepatitis A vaccine | 162 |
| Antitetanus serum | 133 |
| CCHF vaccine (Crimean-Congo Hemorrhagic Fever vaccine) | 88 |
| Other | 16 |
Data as of 05:50 AM on Oct 21st, 2026